RecruitingNot Applicable

National Bacterial Meningitis Study in Children and Newborns

France10,000 participantsStarted 2001-01-01

Plain-language summary

Bacterial meningitis is a major cause of morbidity and mortality in childhood. Antibiotic treatment recommendations are based on epidemiological and susceptibility data. The epidemiology of bacterialméningitis has changed in recent years, mainly owing to widespread use of different conjugate vaccines. The aim of this prospective national survey is to describe epidemiology of bacteria implicated in bacterial meningitis in children.

Who can participate

Age range1 Day – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * clinical signs of meningitis, associated with positive cerebrospinal fluid (CSF) culture and/or positive CSF antigen testing (Escherichia coli K1, N. meningitidis serogroups B, A, C, Y and W-135, group B streptococci, Hib, or S. pneumoniae), and/or positive CSF polymerase chain reaction (PCR), and/or positive blood culture with CSF pleocytosis (\> 10 cells/µL). * purpura fulminans Exclusion Criteria: \-

What they're measuring

mortality

Timeframe: before the hospital discharge

Trial details

NCT IDNCT04664569

SponsorAssociation Clinique Thérapeutique Infantile du val de Marne

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-01-01

Contact for this trial

Corinne Levy, MD

0033148850404 corinne.levy@activ-france.fr

View on ClinicalTrials.gov More Meningitis trials